Latest filing published 14 Dec 2018 for CytomX Therapeutics, Inc., €3,842.
Filing timeline
BuySaleInsider track record
Debanjan Ray: trading record in brief
Debanjan Ray is a declared insider of CytomX Therapeutics, Inc., with filings sourced from SEC (Form 4). Between 31 May 2017 and 12 December 2018, the trades on record add up to 37 filings.
No open-market purchase appears, only 21 sales worth €1.6M. Besides market trades, the filings include 3 share grants and 13 option exercises. So far in 2018, the count stands at no purchases and 15 sales.
On 14 December 2018 came the latest disclosure, an option exercise for €3,842 in CytomX Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Debanjan Ray
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,000 shares@ US$1.450.3% of flowCommon StockSEC:0001567619-18-008005:0
- 3,000 shares@ US$15.002.6% of flowCommon StockSEC:0001567619-18-008005:1
- 3,000 shares@ US$1.450.2% of flowCommon StockSEC:0001567619-18-005082:0
- 3,000 shares@ US$15.002.5% of flowCommon StockSEC:0001567619-18-005082:1
- 3,000 shares@ US$1.450.2% of flowCommon StockSEC:0001567619-18-003477:0
- 3,000 shares@ US$18.462.9% of flowCommon StockSEC:0001567619-18-003477:1
- 3,000 shares@ US$1.450.2% of flowCommon StockSEC:0001567619-18-002232:0
- 3,000 shares@ US$22.393.6% of flowCommon StockSEC:0001567619-18-002232:1
- 2,710 shares@ US$1.260.2% of flowCommon StockSEC:0001140361-18-035277:0
- 290 shares@ US$1.450.0% of flowCommon StockSEC:0001140361-18-035277:1
- 3,000 shares@ US$26.054.0% of flowCommon StockSEC:0001140361-18-035277:2
- 3,000 shares@ US$1.260.2% of flowCommon StockSEC:0001140361-18-031328:0
- 3,000 shares@ US$22.563.4% of flowCommon StockSEC:0001140361-18-031328:1
- 1,187 shares@ US$17.901.0% of flowCommon StockSEC:0001140361-18-027475:0
- 3,000 shares@ US$1.260.2% of flowCommon StockSEC:0001140361-18-027475:1
- 3,000 shares@ US$25.933.8% of flowCommon StockSEC:0001140361-18-027475:2
- 3,000 shares@ US$1.260.2% of flowCommon StockSEC:0001140361-18-021345:0
- 3,000 shares@ US$26.523.8% of flowCommon StockSEC:0001140361-18-021345:1
- 3,000 shares@ US$1.260.2% of flowCommon StockSEC:0001140361-18-016993:0
- 3,000 shares@ US$28.123.9% of flowCommon StockSEC:0001140361-18-016993:1
- 13,000 shares@ US$1.260.8% of flowCommon StockSEC:0001140361-18-012009:0
- 13,000 shares@ US$29.4017.9% of flowCommon StockSEC:0001140361-18-012009:1
- 5,515 shares@ US$1.260.3% of flowCommon StockSEC:0001140361-18-012009:2
- 5,515 shares@ US$30.067.7% of flowCommon StockSEC:0001140361-18-012009:3
- 14,485 shares@ US$1.130.8% of flowCommon StockSEC:0001140361-18-012009:4
25 of 37 declarations